Letter to the Editor: Intrahepatic IgA complex induces polarization of cancer-associated fibroblasts to matrix phenotypes in the tumor microenvironment of hepatocellular carcinoma.
作者信息
Ma Shuangshuang, Chen Jiao, Li Jinpeng
机构信息
Department of Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People's Republic of China.
Department of Interventional Therapy I, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People's Republic of China.
出版信息
Hepatology. 2025 Apr 1;81(4):E121-E122. doi: 10.1097/HEP.0000000000001197. Epub 2024 Dec 23.
Abstract
摘要
相似文献
1
Letter to the Editor: Intrahepatic IgA complex induces polarization of cancer-associated fibroblasts to matrix phenotypes in the tumor microenvironment of hepatocellular carcinoma.致编辑的信：肝内免疫球蛋白A复合物在肝细胞癌肿瘤微环境中诱导癌症相关成纤维细胞向基质表型极化。
Hepatology. 2025 Apr 1;81(4):E121-E122. doi: 10.1097/HEP.0000000000001197. Epub 2024 Dec 23.
2
Reply: Intrahepatic IgA complex induces polarization of cancer-associated fibroblasts to matrix phenotypes in the tumor microenvironment of hepatocellular carcinoma.回复：肝内免疫球蛋白A复合物在肝细胞癌的肿瘤微环境中诱导癌症相关成纤维细胞向基质表型极化。
Hepatology. 2025 Apr 1;81(4):E123-E124. doi: 10.1097/HEP.0000000000001253. Epub 2025 Jan 28.
3
Intrahepatic IgA complex induces polarization of cancer-associated fibroblasts to matrix phenotypes in the tumor microenvironment of HCC.肝内 IgA 复合物诱导 HCC 肿瘤微环境中的癌相关成纤维细胞向基质表型极化。
Hepatology. 2024 Nov 1;80(5):1074-1086. doi: 10.1097/HEP.0000000000000772. Epub 2024 Feb 15.
4
Tumor Microenvironment: Necroptosis Switches the Subtype of Liver Cancer While Necrosis Promotes Tumor Recurrence and Progression.肿瘤微环境：坏死性凋亡改变肝癌亚型，而坏死促进肿瘤复发和进展。
Exp Clin Transplant. 2023 Apr;21(4):291-298. doi: 10.6002/ect.2021.0457. Epub 2022 Mar 15.
5
Intrahepatic inflammatory IgAPD-L1 monocytes in hepatocellular carcinoma development and immunotherapy.肝内炎症性 IgAPD-L1 单核细胞在肝细胞癌发展和免疫治疗中的作用。
J Immunother Cancer. 2022 May;10(5). doi: 10.1136/jitc-2021-003618.
6
A CFH peptide-decorated liposomal oxymatrine inactivates cancer-associated fibroblasts of hepatocellular carcinoma through epithelial-mesenchymal transition reversion.载 CFH 肽的脂质体氧化苦参碱通过上皮间质转化逆转抑制肝癌相关成纤维细胞。
J Nanobiotechnology. 2022 Mar 5;20(1):114. doi: 10.1186/s12951-022-01311-1.
7
Identifying cancer-associated fibroblasts as emerging targets for hepatocellular carcinoma.将癌症相关成纤维细胞鉴定为肝细胞癌的新靶点。
Cell Biosci. 2020 Oct 31;10(1):127. doi: 10.1186/s13578-020-00488-y.
8
Immune microenvironment of hepatocellular carcinoma, intrahepatic cholangiocarcinoma and liver metastasis of colorectal adenocarcinoma: Relationship with histopathological and molecular classifications.肝细胞癌、肝内胆管癌及结直肠癌肝转移的免疫微环境：与组织病理学和分子分类的关系
Hepatol Res. 2021 Jan;51(1):5-18. doi: 10.1111/hepr.13539. Epub 2020 Jul 15.
9
Arenobufagin modulation of PCSK9-mediated cholesterol metabolism induces tumor-associated macrophages polarisation to inhibit hepatocellular carcinoma progression.蟾蜍灵通过调节 PCSK9 介导的胆固醇代谢诱导肿瘤相关巨噬细胞极化抑制肝癌进展。
Phytomedicine. 2024 Jun;128:155532. doi: 10.1016/j.phymed.2024.155532. Epub 2024 Mar 13.
10
Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and Cholangiocarcinoma.肝癌和胆管癌中的癌相关成纤维细胞。
Cell Mol Gastroenterol Hepatol. 2023;15(4):985-999. doi: 10.1016/j.jcmgh.2023.01.006. Epub 2023 Jan 25.
引用本文的文献
1
Mitochondrial dysfunction in hepatocellular carcinoma: from metabolism to targeted therapies.肝细胞癌中的线粒体功能障碍：从代谢到靶向治疗
Mol Cell Biochem. 2025 Aug 30. doi: 10.1007/s11010-025-05377-x.
本文引用的文献
1
Exosomal circHIF1A derived from hypoxic-induced carcinoma-associated fibroblasts promotes hepatocellular carcinoma cell malignant phenotypes and immune escape.外泌体 circHIF1A 来源于缺氧诱导的癌相关成纤维细胞，促进肝癌细胞的恶性表型和免疫逃逸。
Int Immunopharmacol. 2024 Sep 10;138:112282. doi: 10.1016/j.intimp.2024.112282. Epub 2024 Jun 26.
2
Intrahepatic IgA complex induces polarization of cancer-associated fibroblasts to matrix phenotypes in the tumor microenvironment of HCC.肝内 IgA 复合物诱导 HCC 肿瘤微环境中的癌相关成纤维细胞向基质表型极化。
Hepatology. 2024 Nov 1;80(5):1074-1086. doi: 10.1097/HEP.0000000000000772. Epub 2024 Feb 15.
3
Immunotherapy of hepatocellular carcinoma: recent progress and new strategy.肝细胞癌的免疫治疗：最新进展与新策略。
Front Immunol. 2023 May 10;14:1192506. doi: 10.3389/fimmu.2023.1192506. eCollection 2023.
Zotero 插件